Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer
Clinical trial NCT00696696 · COMPLETED
Trial details
- NCT number
- NCT00696696
- Sponsor
- NYU Langone Health
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.